Meta, EssilorLuxottica sued over smartglasses technology

Reuters
01/26
UPDATE 1-Meta, <a href="https://laohu8.com/S/ESLOF">EssilorLuxottica</a> sued over smartglasses technology

Updates Jan 23 story to clarify Solos' location in paragraphs 1 and 5.

By Blake Brittain

Jan 23 (Reuters) - Meta Platforms META.O and EssilorLuxottica ESLX.PA were sued in a U.S. court on Friday by a smartglasses maker that claims they copied its technology for their competing wearables.

Solos Technology said in a patent infringement lawsuit filed in Massachusetts federal court that the companies' products rely on "foundational technologies" it developed related to smartglasses audio, sensing, processing and other features.

The lawsuit said Meta's product collaborations with EssilorLuxottica sunglass brands Ray-Ban and Oakley infringe five of its patents. Solos requested "multiple billions of dollars" in damages from Meta and EssilorLuxottica, as well as court orders blocking the alleged infringement.

Spokespeople for Meta and EssilorLuxottica did not immediately respond to requests for comment. A Solos spokesperson said the complaint speaks for itself.

Solos, which is incorporated in Hong Kong and based in Cambridge, Massachusetts, was spun off from Massachusetts-based wearable developer Kopin Corp in 2019. According to the lawsuit, Meta employees had "studied Solos’ products, cited Solos’ patents, interacted with inventors, and gained insight into Solos’ engineering work" before it started selling its smartglasses in 2021.

Solos said revenue from Meta's Ray-Ban smartglasses is projected to generate $10 billion in revenue by 2030.

The case is Solos Technology Ltd v. Meta Platforms Inc, U.S. District Court for the District of Massachusetts, No. 1:26-cv-10304

For Solos: Jameson Pasek, Steve Wang and Keegan Caldwell of Caldwell

For Meta and EssilorLuxottica: attorney information not yet available

(Reporting by Blake Brittain in Washington)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10